FDA seeks input for future guidance on 3D printing at the point of care

Dec 13, 2021 - 01:25 PM
FDA-guidance

The Food and Drug Administration Friday released a on 3D printing of medical devices at the point of care to facilitate input from stakeholders and others to inform future guidance. The agency will accept comments on the paper for 60 days.
 
鈥3D printing at hospitals and other patient-care settings enables health care professionals to quickly create patient-matched devices and anatomical models for surgical planning, as well as many other uses that can help health care facilities rapidly respond to patient needs,鈥 FDA said. 鈥淭he discussion paper we鈥檙e sharing today provides insight into our perspective of the benefits and challenges of 3D printing at hospitals and other points of care and presents a potential approach for regulatory oversight under various scenarios to inform future policy development.鈥

Related News Articles

Headline
FDA finalizes recommendations simplifying approval process for medical devices that use AI
The Food and Drug Administration yesterday released recommendations for streamlining the approval process for medical devices that use artificial intelligence鈥
Headline
FDA clarifies definition of 'remanufacturing' for medical devices needing maintenance
The Food and Drug Administration May 9 released final guidance clarifying the definition of 鈥渞emanufacturing鈥 for reusable medical devices needing鈥
Headline
FDA webinar Oct. 31 on proposed rule for laboratory developed tests聽
On Oct. 31 at 1 p.m. ET, the Food and Drug Administration will host a webinar to review its recent proposed rule for laboratory developed tests,鈥
Headline
FDA updates sterilization standards for medical device makers
The Food and Drug Administration the week of July 24 updated its recognized consensus standards database for medical devices to advance innovation in medical鈥
Headline
FDA releases transition plans for medical device enforcement, authorization after COVID-19 public health emergency
The Food and Drug Administration today released final guidance for transitioning medical device enforcement policies and emergency use authorizations鈥
Headline
FDA approves first disposable duodenoscope
The Food and Drug Administration Friday cleared for marketing in the U.S. the first fully disposable duodenoscope. The EXALT Model D Single-Use Duodenoscope is鈥